Hans C. Lee

Research interests

Publications

• Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

  Journal of Clinical Oncology · 2024 · https://doi.org/10.1200/jco.24.01008

• Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2028631

• Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA

  Blood · 2020 · https://doi.org/10.1182/blood.2019004460

• Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas

  Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-1061-7

• Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30788-0

• The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis

  Journal of Clinical Investigation · 2019 · https://doi.org/10.1172/jci128654

• Pneumonitis in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.08.2035

• Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy

  Journal of Thoracic Oncology · 2018 · https://doi.org/10.1016/j.jtho.2018.11.016

• Randomized Trial of Pleural Fluid Drainage Frequency in Patients with Malignant Pleural Effusions. The ASAP Trial

  American Journal of Respiratory and Critical Care Medicine · 2017 · https://doi.org/10.1164/rccm.201607-1404oc

• ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies

  Science Signaling · 2016 · https://doi.org/10.1126/scisignal.aac4380

• FXR Deficiency Causes Reduced Atherosclerosis inLdlr−/−Mice

  Arteriosclerosis Thrombosis and Vascular Biology · 2006 · https://doi.org/10.1161/01.atv.0000235697.35431.05

• Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

  Proceedings of the National Academy of Sciences · 2006 · https://doi.org/10.1073/pnas.0506982103

• FXR, a multipurpose nuclear receptor

  Trends in Biochemical Sciences · 2006 · https://doi.org/10.1016/j.tibs.2006.08.002

• FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine

  Journal of Lipid Research · 2005 · https://doi.org/10.1194/jlr.m500417-jlr200

• Epoxyisoprostane and Epoxycyclopentenone Phospholipids Regulate Monocyte Chemotactic Protein-1 and Interleukin-8 Synthesis

  Journal of Biological Chemistry · 2002 · https://doi.org/10.1074/jbc.m107602200

• Determinants of Bioactivity of Oxidized Phospholipids

  Arteriosclerosis Thrombosis and Vascular Biology · 2000 · https://doi.org/10.1161/01.atv.20.10.2248

• Role for Peroxisome Proliferator-Activated Receptor α in Oxidized Phospholipid–Induced Synthesis of Monocyte Chemotactic Protein-1 and Interleukin-8 by Endothelial Cells

  Circulation Research · 2000 · https://doi.org/10.1161/01.res.87.6.516

• Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils

  Proceedings of the National Academy of Sciences · 1999 · https://doi.org/10.1073/pnas.96.21.12010

Current projects

No projects listed.